HURA · TuHURA Biosciences, Inc./NV
Market Cap
$129.37M
Shares
63.73M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-21 | 2026-08-20 | |
| 8-K | 2026-08-19 | 2026-08-18 | |
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-14 | — | |
| 8-K | 2026-08-13 | 2026-08-07 | |
| Investor Event Transcript | 2026-08-12 | 2026-09-30 | |
| 8-K | 2026-07-29 | 2026-07-28 | |
| DEF 14A | 2026-07-09 | 2026-08-18 | |
| 8-K | 2026-07-07 | 2026-06-30 | |
| 8-K | 2026-06-17 | — | |
| 8-K | 2026-05-29 | 2026-05-26 | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-05-15 | — | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 8-K/A | 2026-04-30 | 2026-04-02 | |
| 8-K | 2026-04-22 | 2026-04-21 | |
| 8-K | 2026-04-08 | 2026-04-02 | |
| 8-K | 2026-04-01 | — | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-01-30 | 2026-01-29 | |
| 8-K | 2025-12-10 | 2025-12-09 | |
| 8-K | 2025-12-05 | 2025-12-02 | |
| 8-K | 2025-11-25 | — | |
| 8-K | 2025-11-18 | — | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-11-14 | — | |
| 8-K | 2025-11-04 | 2025-11-03 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-10-31 | 2025-10-27 | |
| 8-K | 2025-09-11 | 2025-09-05 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-14 | — | |
| 8-K/A | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-27 | 2025-06-23 | |
| 8-K | 2025-06-24 | 2025-06-23 | |
| 8-K | 2025-06-12 | 2025-06-06 | |
| 8-K | 2025-06-06 | 2025-06-02 | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-07 | 2025-05-05 | |
| 8-K/A | 2025-05-07 | 2025-03-07 | |
| 8-K | 2025-04-01 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-18 | — | |
| 8-K | 2025-03-12 | 2025-03-07 | |
| 8-K | 2025-02-14 | 2025-02-12 | |
| 8-K | 2025-01-03 | 2024-12-27 | |
| 8-K | 2024-12-12 | 2024-12-11 | |
| 8-K | 2024-11-25 | — |
Showing 1–50 of 171 filings
Key facts
CIK
1498382
CUSIP
898920103
13F (30d)
75 filings
74 filers
Visit website
Investor relations